| NOL4L-DT |
|
NOL4L divergent transcript
|
|
2.1E-02 |
|
|
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
| MIR3936HG |
|
MIR3936 host gene
|
|
|
0.861 |
0.269 |
| CADM3-AS1 |
|
CADM3 antisense RNA 1
|
|
|
1.000 |
0.038 |
| KRBOX1 |
C9JBD0
|
KRAB box domain containing 1
|
|
1.8E-02 |
1.000 |
0.077 |
| ACKR2 |
O00590
|
atypical chemokine receptor 2
|
G-protein coupled receptor
|
1.4E-03 |
0.641 |
0.615 |
| BCL2L11 |
O43521
|
BCL2 like 11
|
|
0.89 |
0.510 |
0.731 |
| ENSA |
O43768
|
endosulfine alpha
|
|
0.35 |
0.760 |
0.308 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| COL1A1 |
P02452
|
collagen type I alpha 1 chain
|
|
1.00 |
0.430 |
0.808 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| RPN1 |
P04843
|
ribophorin I
|
Enzyme
|
0.24 |
0.792 |
0.269 |
| BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
| ITGA4 |
P13612
|
integrin subunit alpha 4
|
|
1.0E-04 |
0.558 |
0.769 |
| ETS1 |
P14921
|
ETS proto-oncogene 1, transcription factor
|
Transcription factor
|
0.78 |
0.444 |
0.731 |
| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| ATF3 |
P18847
|
activating transcription factor 3
|
Transcription factor
|
8.9E-02 |
0.494 |
0.885 |
| GGT5 |
P36269
|
gamma-glutamyltransferase 5
|
Enzyme
|
2.2E-11 |
1.000 |
0.077 |
| FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
| CCR3 |
P51677
|
C-C motif chemokine receptor 3
|
G-protein coupled receptor
|
1.3E-04 |
0.527 |
0.808 |
| HBB |
P68871
|
hemoglobin subunit beta
|
|
1.2E-09 |
0.494 |
0.808 |
| CDK6 |
Q00534
|
cyclin dependent kinase 6
|
Kinase
|
0.98 |
0.471 |
0.731 |
| IRF8 |
Q02556
|
interferon regulatory factor 8
|
Transcription factor
|
0.95 |
0.539 |
0.808 |
| PAK2 |
Q13177
|
p21 (RAC1) activated kinase 2
|
Kinase
|
0.97 |
0.653 |
0.538 |